The two primary issues that led to these breaches revolve around AstraZeneca's characterization of the use of its medication in the advertisement. (picture alliance/Getty Images) AstraZeneca is in hot ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A U.S. flag stands next to the AstraZeneca logo during a signing event for documents related to a manufacturing site ...
AstraZeneca has an unwanted hat trick of breaches of the U.K. pharma marketing code. The drugmaker completed the set after someone noticed the same compliance breach in two earlier cases, prompting ...
AstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month starting June 1.
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca announced it will expand the savings programs for its entire US inhaled respiratory portfolio, helping eligible patients pay no more than $35 per month ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results